Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on May 17, 2002; DOI 10.1182/blood-2002-02-0387.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-02-0387v1
100/6/2040    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, C.
Right arrow Articles by Raskind, W. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, C.
Right arrow Articles by Raskind, W. H
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted February 11, 2002
Accepted April 16, 2002

X-linked thrombocytopenia with thalassemia due to a mutation in the amino-finger of GATA-1 affecting DNA-binding rather than FOG-1 interaction

Channing Yu, Kathy K Niakan, Mark Matsushita, George Stamatoyannopooulos, Stuart H Orkin*, and Wendy H Raskind

Division of Hematology/Oncology, Children's Hospital, HHMI, Boston, MA, USA; Howard Hughes Medical Institute, Boston, MA, none; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA, none
Division of Medical genetics, University of Washington, Seattle, WA, USA
Division of Hematology/Oncology, Children's Hospital, HHMI, Boston, MA, USA; Howard Hughes Medical Institute, Boston, MA, USA; Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA, USA

* Corresponding author; email: orkin{at}rascal.med.harvard.edu.

Transcription factor GATA-1 is essential for development of erythroid cells and megakaryocytes. Each of its two zinc-fingers is critical for normal function. The C-terminal finger is necessary for DNA binding. The N-finger mediates interaction with FOG-1, a cofactor for GATA-1, and also modulates DNA-binding affinity, notably at complex or "palindromic" GATA sites. Residues of the N-finger mediating interaction with FOG-1 lie on the surface of the N-finger facing away from DNA. Strong sequence conservation of residues facing DNA suggests that this other surface may also have an important role. We report here that a syndrome of X-linked thrombocytopenia with thalassemia in humans is tightly linked to a missense mutation (R216 to Q) in the GATA-1 N-finger. To investigate the functional consequences of this substitution, we used site-directed mutagenesis to alter the corresponding residue in GATA-1. Compared to wild type GATA-1, R216Q GATA-1 shows comparable affinity to single GATA-sites but decreased affinity to palindromic sites. R216Q GATA-1 interacts with FOG-1 comparably to wild type GATA-1. R216Q GATA-1 supports erythroid maturation of GATA-1- erythroid cells, albeit at a reduced efficiency compared to wild type GATA-1. Together, these findings suggest that residues of the N-finger of GATA-1 facing DNA contribute to GATA-1 function apart from interaction with the cofactor FOG-1. This is also the first example of ß-thalassemia in man due to a mutation in an erythroid transcription factor.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
K. E. Elagib, I. S. Mihaylov, L. L. Delehanty, G. C. Bullock, K. D. Ouma, J. F. Caronia, S. L. Gonias, and A. N. Goldfarb
Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation
Blood, December 15, 2008; 112(13): 4884 - 4894.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. L. Balduini, E. De Candia, and A. Savoia
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome"
Blood, October 1, 2007; 110(7): 2770 - 2771.
[Full Text] [PDF]


Home page
haematolHome page
A. T. Nurden and P. Nurden
Inherited thrombocytopenias
Haematologica, September 1, 2007; 92(9): 1158 - 1164.
[Full Text] [PDF]


Home page
BloodHome page
V. N. Tubman, J. E. Levine, D. R. Campagna, R. Monahan-Earley, A. M. Dvorak, E. J. Neufeld, and M. D. Fleming
X-linked gray platelet syndrome due to a GATA1 Arg216Gln mutation
Blood, April 15, 2007; 109(8): 3297 - 3299.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. D. Phillips, D. P. Steensma, M. A. Pulsipher, G. J. Spangrude, and J. P. Kushner
Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria
Blood, March 15, 2007; 109(6): 2618 - 2621.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Ghinassi, M. Sanchez, F. Martelli, G. Amabile, A. M. Vannucchi, G. Migliaccio, S. H. Orkin, and A. R. Migliaccio
The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor
Blood, February 15, 2007; 109(4): 1460 - 1471.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. J. Majewski, D. Metcalf, L. A. Mielke, D. L. Krebs, S. Ellis, M. R. Carpinelli, S. Mifsud, L. Di Rago, J. Corbin, N. A. Nicola, et al.
A mutation in the translation initiation codon of Gata-1 disrupts megakaryocyte maturation and causes thrombocytopenia
PNAS, September 19, 2006; 103(38): 14146 - 14151.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. L. Stachura, S. T. Chou, and M. J. Weiss
Early block to erythromegakaryocytic development conferred by loss of transcription factor GATA-1
Blood, January 1, 2006; 107(1): 87 - 97.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Iolascon, M. d'Apolito, V. Servedio, F. Cimmino, A. Piga, and C. Camaschella
Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)
Blood, January 1, 2006; 107(1): 349 - 354.
[Abstract] [Full Text] [PDF]


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
J. D. Phillips, D. P. Steensma, G. J. Spangrude, and J. P. Kushner
Congenital Erythropoietic Porphyria, {beta}-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation.
Blood (ASH Annual Meeting Abstracts), November 16, 2005; 106(11): 515 - 515.
[Abstract]


Home page
Mol. Cell. Biol.Home page
C. Kuhl, A. Atzberger, F. Iborra, B. Nieswandt, C. Porcher, and P. Vyas
GATA1-Mediated Megakaryocyte Differentiation and Growth Control Can Be Uncoupled and Mapped to Different Domains in GATA1
Mol. Cell. Biol., October 1, 2005; 25(19): 8592 - 8606.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
V. Munugalavadla, L. C. Dore, B. L. Tan, L. Hong, M. Vishnu, M. J. Weiss, and R. Kapur
Repression of c-Kit and Its Downstream Substrates by GATA-1 Inhibits Cell Proliferation during Erythroid Maturation
Mol. Cell. Biol., August 1, 2005; 25(15): 6747 - 6759.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. C. Hughan, Y. Senis, D. Best, A. Thomas, J. Frampton, P. Vyas, and S. P. Watson
Selective impairment of platelet activation to collagen in the absence of GATA1
Blood, June 1, 2005; 105(11): 4369 - 4376.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Zahirieh, M. A. Nesbit, A. Ali, K. Wang, N. He, M. Stangou, G. Bamichas, K. Sombolos, R. V. Thakker, and Y. Pei
Functional Analysis of a Novel GATA3 Mutation in a Family with the Hypoparathyroidism, Deafness, and Renal Dysplasia Syndrome
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2445 - 2450.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. Ferreira, K. Ohneda, M. Yamamoto, and S. Philipsen
GATA1 Function, a Paradigm for Transcription Factors in Hematopoiesis
Mol. Cell. Biol., February 15, 2005; 25(4): 1215 - 1227.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. K. Liew, R. J. Y. Simpson, A. H. Y. Kwan, L. A. Crofts, F. E. Loughlin, J. M. Matthews, M. Crossley, and J. P. Mackay
Zinc fingers as protein recognition motifs: Structural basis for the GATA-1/Friend of GATA interaction
PNAS, January 18, 2005; 102(3): 583 - 588.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
S. L. Thein
Pathophysiology of {beta} Thalassemia--A Guide to Molecular Therapies
Hematology, January 1, 2005; 2005(1): 31 - 37.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. J. Welch, J. A. Watts, C. R. Vakoc, Y. Yao, H. Wang, R. C. Hardison, G. A. Blobel, L. A. Chodosh, and M. J. Weiss
Global regulation of erythroid gene expression by transcription factor GATA-1
Blood, November 15, 2004; 104(10): 3136 - 3147.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Nesbit, M. R. Bowl, B. Harding, A. Ali, A. Ayala, C. Crowe, A. Dobbie, G. Hampson, I. Holdaway, M. A. Levine, et al.
Characterization of GATA3 Mutations in the Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) Syndrome
J. Biol. Chem., May 21, 2004; 279(21): 22624 - 22634.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Ahmed, A. Sternberg, G. Hall, A. Thomas, O. Smith, A. O'Marcaigh, R. Wynn, R. Stevens, M. Addison, D. King, et al.
Natural history of GATA1 mutations in Down syndrome
Blood, April 1, 2004; 103(7): 2480 - 2489.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Shimizu, K. Ohneda, J. D. Engel, C. D. Trainor, and M. Yamamoto
Transgenic rescue of GATA-1-deficient mice with GATA-1 lacking a FOG-1 association site phenocopies patients with X-linked thrombocytopenia
Blood, April 1, 2004; 103(7): 2560 - 2567.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. G. Drachman
Inherited thrombocytopenia: when a low platelet count does not mean ITP
Blood, January 15, 2004; 103(2): 390 - 398.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Gurbuxani, P. Vyas, and J. D. Crispino
Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome
Blood, January 15, 2004; 103(2): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
D. R. Higgs
Ham-Wasserman Lecture: Gene Regulation in Hematopoiesis: New Lessons from Thalassemia
Hematology, January 1, 2004; 2004(1): 1 - 13.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Ghirlando and C. D. Trainor
Determinants of GATA-1 Binding to DNA: THE ROLE OF NON-FINGER RESIDUES
J. Biol. Chem., November 14, 2003; 278(46): 45620 - 45628.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Fossett, K. Hyman, K. Gajewski, S. H. Orkin, and R. A. Schulz
Combinatorial interactions of Serpent, Lozenge, and U-shaped regulate crystal cell lineage commitment during Drosophila hematopoiesis
PNAS, September 30, 2003; 100(20): 11451 - 11456.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Rainis, D. Bercovich, S. Strehl, A. Teigler-Schlegel, B. Stark, J. Trka, N. Amariglio, A. Biondi, I. Muler, G. Rechavi, et al.
Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21
Blood, August 1, 2003; 102(3): 981 - 986.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Mundschau, S. Gurbuxani, A. S. Gamis, M. E. Greene, R. J. Arceci, and J. D. Crispino
Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis
Blood, June 1, 2003; 101(11): 4298 - 4300.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020